
生物谷 — Investor Relations & Filings
Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 股东股权司法冻结的公告 | 2025-08-25 | Chinese | |
| 关于变更持续督导保荐代表人的公告 | 2025-08-24 | Chinese | |
| 2025年半年度报告 | 2025-08-20 | Chinese | |
| 第五届董事会第六次会议决议公告 | 2025-08-20 | Chinese | |
| 2025年半年度报告摘要 | 2025-08-20 | Chinese | |
| 第五届监事会第五次会议决议公告 | 2025-08-20 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39806587 | 股东股权司法冻结的公告 | 2025-08-25 | Chinese | ||
| 39806577 | 关于变更持续督导保荐代表人的公告 | 2025-08-24 | Chinese | ||
| 39806560 | 2025年半年度报告 | 2025-08-20 | Chinese | ||
| 39806516 | 第五届董事会第六次会议决议公告 | 2025-08-20 | Chinese | ||
| 39806511 | 2025年半年度报告摘要 | 2025-08-20 | Chinese | ||
| 39806481 | 第五届监事会第五次会议决议公告 | 2025-08-20 | Chinese | ||
| 39806476 | 股票解除限售公告 | 2025-07-22 | Chinese | ||
| 39806466 | 证券事务代表任命公告 | 2025-07-17 | Chinese | ||
| 39806456 | 第五届董事会第五次会议决议公告 | 2025-07-17 | Chinese | ||
| 39806447 | 关于完成工商变更登记并取得换发营业执照的公告 | 2025-07-02 | Chinese | ||
| 39806436 | 关于对北京证券交易所2024年年报问询函的回复 | 2025-07-02 | Chinese | ||
| 39806412 | 信永中和会计师事务所(特殊普通合伙)关于对云南生物谷药业股份有限公司2024 年年报问询函的回复 | 2025-07-02 | Chinese | ||
| 39806410 | 简式权益变动报告书(深圳市金沙江投资有限公司、林艳和) | 2025-06-03 | Chinese | ||
| 39806305 | 关于股东解除投票权委托协议暨权益变动的提示性公告 | 2025-06-03 | Chinese | ||
| 39806294 | 简式权益变动报告书(新意资本基金管理(深圳)有限公司) | 2025-06-03 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
生物谷 via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58793/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58793 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58793 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58793 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58793}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 生物谷 (id: 58793)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.